Baotou Dongbao Bio-Tech (300239) Stock Overview

Baotou Dongbao Bio-Tech Co.,Ltd engages in the research and development, production, and sale of gelatin, collagen, and additional products in the People's Republic of China and internationally. It offers gelatin for jelly, confection, yogurt, plasma substitute, tablets, softgel, photographic paper, and hard capsules; plasma gelatin substitute, hollow capsule, double protein dietary fiber, cosmetics, and other products; agglomerated collagen peptide; hydrolyzed collagen power and granule; collagen peptide power and granule; hydrolyzed fish collagen; collagen jars; and fish collagen peptide powder, as well as food additive and pharmaceutical gelatin. The company also engages in research and development, production, and sale of bio-organic fertilizers, including industrial and feed grade calcium hydrogen phosphate; inorganic and organic microorganisms fertilizers; nitrogen fertilizers; calcium amino acid fertilizer; bone-derived biological calcium fertilizer; and biological and refined organic fertilizer. In addition, it is involved in the research and development, production, and sale of empty capsules. The company was founded in 1960 and is based in Baotou, the People's Republic of China.